Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05903027

Gepant treAtments: EffectIveNess and tolERability (GAINER)

Sponsor: University of Florence

View on ClinicalTrials.gov

Summary

The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of rimegepant as acute migraine treatment in a cohort of episodic or chronic migraine patients.

Official title: Effectiveness and Tolerability of Rimegepant as Acute Migraine Treatment: a Prospective, Multicentric, Cohort Study (GAINER)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2023-06-15

Completion Date

2026-09-15

Last Updated

2026-01-21

Healthy Volunteers

No

Interventions

DRUG

Rimegepant 75 MG Disintegrating Oral Tablet

Patients using Rimegepant 75 mg orally disintegrating tablet to treat acute migraine attacks

Locations (2)

SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi

Florence, Italy

IRCCS National Neurological Institute "C. Mondino" Foundation

Pavia, Italy